Viewing StudyNCT03250338



Ignite Creation Date: 2024-05-06 @ 10:26 AM
Last Modification Date: 2024-10-26 @ 12:29 PM
Study NCT ID: NCT03250338
Status: UNKNOWN
Last Update Posted: 2021-04-30
First Post: 2017-08-11

Brief Title: Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in RR FLT3 Mutated AML
Sponsor: Arog Pharmaceuticals Inc
Organization: Arog Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-06-05
Start Date Type: ACTUAL
Primary Completion Date: 2024-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-10
Completion Date Type: ESTIMATED
First Submit Date: 2017-08-11
First Submit QC Date: August 14 2017
Study First Post Date: 2017-08-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-04-28
Last Update Post Date: 2021-04-30
Last Update Post Date Type: ACTUAL